Yelena Novik, MD

Articles

Dr Novik on Emergent Treatment Options in ER+ Breast Cancer

January 8th 2024

Yelena Novik, MD, discusses advancements and emerging trends that have been seen in the treatment of patients with advanced estrogen-receptor–positive breast cancer, citing clinical trials that have helped push the treatment armamentarium forward.

Dr. Novik on Benefits/Challenges of Implementing Biosimilars

August 21st 2018

Yelena Novik, MD, associate professor, New York University’s Perlmutter Cancer Center, discusses the benefits and challenges of the global implementation of biosimilars.

Dr. Novik on CDK4/6 Inhibitor Combinations in Breast Cancer

August 10th 2018

Yelena Novik, MD, associate professor, NYU Langone’s Perlmutter Cancer Center, discusses CDK4/6 inhibitor combinations in breast cancer.

Dr. Novik on the Potential Impact of Biosimilars on Cancer Treatment

July 12th 2018

Yelena Novik, MD, associate professor, New York University’s Perlmutter Cancer Center, discusses the potential impact of biosimilars on the treatment of cancer.

Dr. Novik on the Sustainability of Drug Development

June 29th 2018

Yelena Novik, MD, associate professor, New York University Langone’s Perlmutter Cancer Center, discusses the sustainability of drug development in oncology.

Dr. Novik on the Adoption of Biosimilars in Breast Cancer

June 23rd 2018

Yelena Novik, MD, associate professor, Department of Medicine, New York University’s Perlmutter Cancer Center, discusses the adoption of biosimilars in breast cancer.